<DOC>
	<DOCNO>NCT01091896</DOCNO>
	<brief_summary>The purpose study determine effect pre intra-operative bevacizumab injection postoperative vitreous hemorrhage diabetic vitrectomy comparison vitrectomy without bevacizumab injection .</brief_summary>
	<brief_title>Adjuvant Intravitreal Bevacizumab Pars Plana Vitrectomy Vitreous Hemorrhage</brief_title>
	<detailed_description>Postoperative vitreous hemorrhage common complication vitrectomy proliferative diabetic retinopathy . Bevacizumab ( Avastin ) potent inhibitor angiogenesis show decrease retinal iris neovascularization proliferative diabetic retinopathy . We believe preoperative bevacizumab injection could reduce postoperative vitreous hemorrhage decrease amount abnormal vessel intraoperative injection could also reduce postoperative vitreous hemorrhage inhibit vessel formation surgery</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Vitreous Hemorrhage</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>patient undergo first vitrectomy vitreous hemorrhage secondary proliferative diabetic retinopathy followup period le 3 month first vitrectomy abnormal blood coagulation uncontrolled hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>bevacizumab</keyword>
	<keyword>vitreous hemorrhage</keyword>
	<keyword>diabetes mellitus</keyword>
</DOC>